Editor’s Note
**Editor’s Note:** Amorepacific Holdings has announced a strategic investment in Hiel Corporation, a specialist in aesthetic medical devices, marking a new collaboration in the beauty and medical sectors. The partnership aims to jointly develop next-generation solutions.
Amorepacific Holdings and Hiel Corporation, a specialized company in aesthetic medical devices, have announced a collaboration in the beauty and medical fields. As part of this partnership, Amorepacific Holdings has made a strategic investment in Hiel Corporation, announced on the 27th.
The collaboration will expand across product planning, R&D, distribution, and marketing. They aim to develop and commercialize skin boosters, cosmeceuticals, and medical devices, as well as post-treatment care products and distribution partnerships with hospitals and clinics.
The core of this partnership lies in combining Hiel Corporation’s expertise in aesthetic medical device development, joint research with medical professionals, and global Key Opinion Leader (KOL) network with Amorepacific’s dermatological research and skincare technology. Based on this, the two companies plan to develop integrated solutions that bridge professional treatments and daily skincare.
Founded in 2021, Hiel Corporation is a specialized aesthetic medical device company that conducts R&D based on a medical professional network and global business operations. Its flagship product, ‘HILO WAVE,’ has driven expansion in South Korea, Japan, Indonesia, Vietnam, and other markets, while continuing to strengthen global partnerships and accumulate clinical evidence.